CMA
TWST icon

Cedar Mountain Advisors’s Twist Bioscience TWST Stock Holding History

Cedar Mountain Advisors’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-50
Closed -$1.72K – 353
2024
Q1 		$1.72K Hold
50
– – ﹤0.01% 283
2023
Q4 		$1.84K Hold
50
– – ﹤0.01% 270
2023
Q3 		$1.01K Hold
50
– – ﹤0.01% 272
2023
Q2 		$1.02K Hold
50
– – ﹤0.01% 263
2023
Q1 		$754 Hold
50
– – ﹤0.01% 273
2022
Q4 		$1.19K Hold
50
– – ﹤0.01% 265
2022
Q3 		$2K Hold
50
– – ﹤0.01% 264
2022
Q2 		$2K Hold
50
– – ﹤0.01% 265
2022
Q1 		$2K Hold
50
– – ﹤0.01% 277
2021
Q4 		$4K Hold
50
– – ﹤0.01% 251
2021
Q3 		$5K Hold
50
– – ﹤0.01% 234
2021
Q2 		$7K Hold
50
– – ﹤0.01% 194
2021
Q1 		$6K Hold
50
– – ﹤0.01% 210
2020
Q4 		$7K Buy
+50
New +$5.55K ﹤0.01% 195

Other funds holding TWST

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Cedar Mountain Advisors's TWST Position: Q2 2024 in Review

Cedar Mountain Advisors sold out of Twist Bioscience (TWST) in Q2 2024, closing a stake of 50 shares — an estimated $1.72K sold.

Cedar Mountain Advisors first reported a position in TWST in Q4 2020 and held it in 14 quarters. The position peaked at $7K in Q2 2021. 262 funds tracked by Wall St. Rank hold TWST as of Q2 2024.

  • Cedar Mountain Advisors reported no remaining Twist Bioscience position as of Q2 2024 after selling out during the quarter.
  • Cedar Mountain Advisors sold 50 Twist Bioscience shares in Q2 2024, an estimated $1.72K.
  • Cedar Mountain Advisors first reported a position in Twist Bioscience in Q4 2020 and held it in 14 quarters.
  • Cedar Mountain Advisors's Twist Bioscience position peaked at $7K in Q2 2021.
  • 262 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2024.

Based on Cedar Mountain Advisors's 13F filing for Q2 2024, filed 11 Jul 2024.